📰 Bio Path News
Bio Path News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Bio Path. Real-time updates on events, politics, business and more.
May 4, 2024
StockNews.com started coverage on shares of Bio-Path (NASDAQ:BPTH – Free Report) in a research note issued to investors on Thursday morning. The firm issued a sell rating on the stock. Separately, Roth Mkm reaffirmed a buy rating and set a $40.00 price target on shares of Bio-Path in a research report on Thursday, April 18th. […]
April 27, 2024
StockNews.com started coverage on shares of Bio-Path (NASDAQ:BPTH – Free Report) in a report published on Wednesday. The firm issued a sell rating on the stock. Separately, Roth Mkm reissued a buy rating and set a $40.00 price objective on shares of Bio-Path in a research report on Thursday, April 18th. Get Our Latest Research […]
March 29, 2024
Bio-Path Holdings, Inc. (NASDAQ:BPTH – Get Free Report) was the recipient of a significant increase in short interest in March. As of March 15th, there was short interest totalling 63,400 shares, an increase of 284.2% from the February 29th total of 16,500 shares. Approximately 9.6% of the shares of the company are short sold. Based […]
March 27, 2024
Bio-Path Holdings, Inc. (NASDAQ:BPTH – Get Free Report) saw a large increase in short interest in the month of March. As of March 15th, there was short interest totalling 63,400 shares, an increase of 284.2% from the February 29th total of 16,500 shares. Currently, 9.6% of the shares of the company are short sold. Based […]
March 11, 2024
StockNews.com assumed coverage on shares of Bio-Path (NASDAQ:BPTH – Free Report) in a research note published on Thursday. The firm issued a sell rating on the stock. Bio-Path Price Performance Shares of Bio-Path stock opened at $5.83 on Thursday. Bio-Path has a 1 year low of $4.60 and a 1 year high of $44.80. The […]
January 28, 2024
Bio-Path (NASDAQ:BPTH – Get Free Report) and MannKind (NASDAQ:MNKD – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, risk, analyst recommendations, earnings, valuation, profitability and institutional ownership. Institutional & Insider Ownership 5.7% of Bio-Path shares are […]
January 7, 2024
StockNews.com started coverage on shares of Bio-Path (NASDAQ:BPTH – Free Report) in a report issued on Wednesday morning. The firm issued a sell rating on the stock. Bio-Path Stock Up 10.3 % Bio-Path stock opened at $0.55 on Wednesday. The company’s 50-day moving average price is $0.53 and its 200-day moving average price is $0.68. […]
January 4, 2024
StockNews.com assumed coverage on shares of Bio-Path (NASDAQ:BPTH – Free Report) in a research report report published on Wednesday. The brokerage issued a sell rating on the stock. Bio-Path Stock Performance Shares of BPTH stock opened at $0.49 on Wednesday. Bio-Path has a 52-week low of $0.32 and a 52-week high of $2.35. The firm […]
January 2, 2024
Bio-Path Holdings, Inc. (NASDAQ:BPTH – Get Free Report) saw a large decline in short interest in the month of December. As of December 15th, there was short interest totalling 430,900 shares, a decline of 18.6% from the November 30th total of 529,600 shares. Based on an average trading volume of 2,660,000 shares, the days-to-cover ratio […]
December 3, 2023
Bio-Path Holdings, Inc. (NASDAQ:BPTH – Get Free Report) saw a large decrease in short interest during the month of November. As of November 15th, there was short interest totalling 695,700 shares, a decrease of 28.2% from the October 31st total of 969,600 shares. Based on an average daily trading volume, of 2,640,000 shares, the short-interest […]